

SMART Antiviral Prize: Info Session & Live Q&A
Have questions about the SMART Antiviral Prize? Join one of our info sessions to learn more about the prize challenge details, the application process, and what we’re looking for.
What to Expect:
SMART Antiviral Prize overview and scope
Applicant eligibility and solution focus areas
Evaluation criteria and key dates
Application tips and best practices
You’ll also have the opportunity to engage directly with the VITAL team during a live Q&A.
Who should Attend:
Researchers, biotechs, innovators, AI and drug discovery teams, and others working on broad spectrum small molecule antiviral solutions.
We’re hosting multiple info sessions to fit your schedule. Below are all available dates:
Wednesday, Feb 25 at 11 AM EST
Thursday, Mar 19 at 8 AM EDT
Thursday, Apr 2 at 11 AM EDT
Tuesday, Apr 21 at 11 AM EDT
You can view all registration pages and sign up for individual sessions HERE.
BARDA Accelerator Network (BAN)
Established by the Biomedical Advanced Research and Development Authority (BARDA), part of the Administration for Strategic Preparedness and Response (ASPR) within the U.S. Department of Health and Human Services (HHS), the BARDA Accelerator Network (BAN) fosters the growth of health security innovation ecosystems globally and accelerates the development and commercialization of next-generation health security solutions.
The BAN, comprised of 5 hubs, will serve as a global network supporting early-stage companies from around the world developing next-generation medical countermeasures (MCMs). The Hubs are focused on Diagnostics/Medical Devices, Therapeutics/Vaccines, Digital Health Tools, Special Populations, and Enabling Technologies.
VITAL is a BARDA Accelerator Network (BAN) Hub supporting the development and acceleration of next-generation therapeutic platforms and technologies to promote health security. It is led by Start2 Group in partnership with Advise Connect Inspire (ACI) and BioInnovation Labs (BioLabs). VITAL provides a global innovation network to enable impactful collaborations between the U.S. and other health security communities and their innovation ecosystems around the world.